| abstract |
The invention relates to a pharmaceutical composition, and methods of using a pharmaceutical composition, for the treatment of osteoarthritis in a subject in need thereof, the pharmaceutical composition containing cannabidiol or a pharmaceutically acceptable salt thereof. ; the administration of cannabidiol is, in particular, through a transdermal gel pharmaceutical composition. The invention also relates to a method of treating one or more symptoms of osteoarthritis in a patient. The method comprises transdermally delivering an effective amount of cannabidiol (CBD) to the patient, wherein one or more symptoms of osteoarthritis are treated in the patient. |